• Applications
  • Intrinsically disordered proteins

    How it works
    Characterizing intrinsically disordered proteins (IDPs) is challenging due to their lack of stable structures, making traditional structural and functional characterization methods less applicable. MDS offers studying such challenging targets directly in solution and bypasses restrictions associated with surface-based methods. 
    Overview

    Intrinsically disordered proteins (IDPs) lack a well-defined three-dimensional structure under physiological conditions. Instead, they exist as dynamic ensembles of conformations and play crucial roles in various cellular processes, often involving interactions with other proteins, nucleic acids, or small molecules. Due to their inherent flexibility and ability to adopt multiple conformations, IDPs are implicated in a wide range of disease areas such as neurodegenerative disease, oncology, or viral infections. To understand IDP interactions, tethering them to a surface can be problematic and does not replicate the dynamic and flexible nature of IDPs in their native environment, limiting the relevance and accuracy of the obtained data. Microfluidic diffusional sizing (MDS) avoids surface immobilization and thus preserves the native flexibility and dynamic behavior of IDPs reducing the risk of inducing artificial structures and provides a more accurate representation of the IDPs’ behavior and interactions.

    MDS benefits over surface immobilization methods
    2D surface
    • IDPs are difficult to attach to a surface
    • Surface tethering affects IDP structural dynamics and induces non-native or inactive conformations
    • Limited relevance of obtained data
    3D diffusion sizing
    • In-solution approach eliminates time-consuming immobilization setup
    • Preserves structural dynamics and native conformational ensemble
    • Physiologically relevant data
    Case Study
    Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies.
    Get started

    To study intrinsically-disordered or aggregated proteins in their native state in solution we recommend the following:

    Workflow specification and benefits:
    • 25 min run time  
    • KD range from pM to µM   
    • Provides stoichiometry 
    • Amount of antibody 1-10 µ g depending on affinity  
    • Amount of oligomer or fibril 10-25 µ g 
    • 4 µ L of sample 
    • Use of complex background e.g. serum, lysate, CSF 
    • Quick & easy to perform 

    Could we support your research? Get in touch